Teriparatide [RHPTH (1-34)] treatment reduces the incidence of back pain in postmenopausal women with osteoporosis

被引：0
|
作者：
Krege, JH
Xie, L
Genant, HK
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] UCSF, San Francisco, CA USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [11] Teriparatide reduces the incidence of new or worsening back pain in women with osteoporosis.
    Genant, HK
    Scheele, WH
    Xie, L
    Krege, JH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S385 - S385
  • [12] Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy
    Ste-Marie, LG
    Schwartz, SL
    Hossain, A
    Desaiah, D
    Gaich, GA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (02) : 283 - 291
  • [13] TERIPARATIDE (RHPTH [1-34]) TREATMENT IMPROVES THE STRUCTURE OF THE PROXIMAL FEMUR IN WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FRACTURE PREVENTION TRIAL
    Scmanick, L. M.
    Uusi-Rasi, K.
    Zanchetta, J. R.
    Bogado, C. E.
    Eriksen, E. F.
    Sato, M.
    Beck, T. J.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S37 - S37
  • [14] CHANGES IN QUALITY OF LIFE AND BACK PAIN IN WOMEN WITH OSTEOPOROSIS TREATED WITH RHPTH(1-34) (TERIPARATIDE): 36 MONTH RESULTS FROM THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)
    Fahrleitner-Pammer, A.
    Ljunggren, O.
    Langdahl, B.
    Walsh, B.
    Barker, C.
    Lems, W.
    Karras, D.
    Rajzbaum, G.
    Jakob, F.
    Barrett, A.
    Marin, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 156 - 157
  • [15] The response of back pain to 12 months of teriparatide (RHPTH1-34) in women with postmenopausal osteoporosis depends on the degree of baseline pain: Subgroup analyses from the EUROFORS study
    Lyritis, G.
    Minne, H.
    Farrerons, J.
    Brixen, K.
    Ochs, P.
    Ginis, A.
    Skytte, Jensen M.
    Nickelsen, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S233 - S234
  • [16] Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
    Moca Trevisani, Virginia Fernandes
    Riera, Rachel
    Imoto, Aline Mizusaki
    Saconato, Humberto
    Atallah, Alvaro Nagib
    [J]. SAO PAULO MEDICAL JOURNAL, 2008, 126 (05): : 279 - 284
  • [17] Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women
    Uusi-Rasi, K
    Semanick, LM
    Zanchetta, JR
    Bogado, CE
    Eriksen, EF
    Sato, M
    Beck, TJ
    [J]. BONE, 2005, 36 (06) : 948 - 958
  • [18] Distinctive effects of teriparatide [rhPTH(1-34)] and alendronate on bone turnover and lumbar spine bone density in women with osteoporosis
    McClung, MR
    Miller, PD
    Civitelli, R
    Warren, ML
    Greenspan, SL
    Tamayo, JA
    Donley, DW
    San Martin, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S18 - S18
  • [19] Teriparatide (rhPTH(1-34) improves the structural geometry of the hip
    Uusi-Rasi, K
    Beck, TJ
    Oreskovic, TL
    Sato, M
    Boado, CE
    Zanchetta, JR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S208 - S208
  • [20] REDUCTION IN BACK PAIN FOLLOWING TERIPARATIDE COMPARED WITH ALENDRONATE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Dore, R. K.
    Krege, J. H.
    Chen, P.
    Glass, E. V.
    Martin, J. San
    Miller, P. D.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S89 - S89
12345